The U.S. Food and Drug Administration and the Nuclear Regulatory Commission (NRC) today took steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases. The FDA approved the RadioGenix System, a unique system for producing Technetium-99m (Tc-99m), the most widely used radioisotope in medical imaging. The NRC is issuing guidance and will license the RadioGenix System to enable the Tc-99m it produces to be used for its medical purpose. Continue reading.
Ophthalmology Research Seminar: Distinguished Speaker Series
Hace 29 minutos